SCHEMBL352447

SCHEMBL352447

CCC(C)CCCCCCCCCCCCCCCO

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.46
ALDH1A1 P00352 3/20 0.46
TSHR P16473 3/20 0.46
HSD17B10 Q99714 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.41
ACE2 Q9BYF1 1/20 0.39
PRKD3 O94806 1/20 0.34
PRKCG P05129 1/20 0.34
PRKCB P05771 1/20 0.34
PRKCA P17252 1/20 0.34
PRKCH P24723 1/20 0.34
PRKCI P41743 1/20 0.34
PRKCE Q02156 1/20 0.34
PRKCQ Q04759 1/20 0.34
PRKCZ Q05513 1/20 0.34
PRKCD Q05655 1/20 0.34
PRKD1 Q15139 1/20 0.34
SPHK1 Q9NYA1 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4288193 1.00 LMNA (0.46) LMNAALDH1A1TSHRHSD17B10MEN1
SCHEMBL1658874 1.00 LMNA (0.46) LMNAALDH1A1TSHRHSD17B10MEN1
SCHEMBL352274 1.00 LMNA (0.46) LMNAALDH1A1TSHRHSD17B10MEN1
SCHEMBL345863 1.00 LMNA (0.46) LMNAALDH1A1TSHRHSD17B10MEN1
SCHEMBL9488487 1.00 LMNA (0.46) LMNAALDH1A1TSHRHSD17B10MEN1
SCHEMBL3772105 1.00 LMNA (0.46) LMNAALDH1A1TSHRHSD17B10MEN1
SCHEMBL4779607 1.00 LMNA (0.46) LMNAALDH1A1TSHRHSD17B10MEN1
SCHEMBL1658809 1.00 LMNA (0.46) LMNAALDH1A1TSHRHSD17B10MEN1
SCHEMBL351960 1.00 LMNA (0.46) LMNAALDH1A1TSHRHSD17B10MEN1
SCHEMBL1409158 1.00 LMNA (0.46) LMNAALDH1A1TSHRHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8603449-B2 Rinse-off conditioning composition comprising a near-terminal branched alcohol THE PROCTER & GAMBLE COMPANY (US) 2013-12-10 US claimed
EP-2593073-A2 RINSE-OFF CONDITIONING COMPOSITION COMPRISING A NEAR-TERMINAL BRANCHED ALCOHOL The Procter and Gamble Company (US) 2013-05-22 EP claimed
US-20120014901-A1 Rinse-Off Conditioning Composition Comprising a Near-Terminal Branched Alcohol THE PROCTER & GAMBLE COMPANY 2012-01-19 US claimed
WO-2012009522-A2 RINSE-OFF CONDITIONING COMPOSITION COMPRISING A NEAR-TERMINAL BRANCHED ALCOHOL THE PROCTER & GAMBLE COMPANY (US) 2012-01-19 WO claimed
EP-0452941-B1 Use of isomonools in the treatment and prophylaxis of cancer DAI ICHI KOGYO SEIYAKU CO LTD (JP) 1996-03-06 EP claimed
US-5162304-A Higher Isoalkyl Alcohols DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) 1992-11-10 US claimed
EP-2298856-B1 GREASE COMPOSITION FOR CONSTANT VELOCITY JOINT AND CONSTANT VELOCITY JOINT KYODO YUSHI (JP) 2019-12-25 EP disclosed
EP-2939659-B1 HAIR CLEANSING COMPOSITION KAO CORP (JP) 2018-05-30 EP disclosed
EP-2939658-B1 GEL HAIR COSMETIC KAO CORP (JP) 2018-01-31 EP disclosed
US-9849075-B2 Gel hair cosmetic KAO CORPORATION (JP) 2017-12-26 US disclosed
US-9566217-B2 Hair cleansing composition KAO CORPORATION (JP) 2017-02-14 US disclosed
US-9434641-B2 Method for protecting glass surface using long-chain organic material CORNING INCORPORATED (US) 2016-09-06 US disclosed
US-9434641-B2 Method for protecting glass surface using long-chain organic material CORNING INCORPORATED (US) 2016-09-06 US disclosed
WO-2002081719-A1 METHOD FOR PRODUCING FATS OR OILS ARCHER-DANIELS-MIDLAND COMPANY (US) 2002-10-17 WO disclosed
US-5763497-A SOLID PHASE CREAM COMPRISING A WAX ESTER FROM FATTY ACID AND FATTY ALCOHOL; SMOOTH FEELINGS, STORAGE STABILITY; LIPSTICK, EYE SHADOW, COSMETIC FOUNDATION SHISEIDO COMPANY, LTD. (JP) 1998-06-09 US disclosed
EP-0452941-B1 Use of isomonools in the treatment and prophylaxis of cancer DAI ICHI KOGYO SEIYAKU CO LTD (JP) 1996-03-06 EP disclosed
US-5162304-A Higher Isoalkyl Alcohols DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) 1992-11-10 US disclosed
EP-0452941-A2 Use of isomonools in the treatment and prophylaxis of cancer DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) 1991-10-23 EP disclosed
EP-0222411-B1 METHOD OF PREPARING SUSTAINED-RELEASE PHARMACEUTICAL PREPARATION TAISHO PHARMACEUTICAL CO. LTD (JP) 1991-08-14 EP disclosed
EP-0222411-A2 Method of preparing sustained-release pharmaceutical preparation TAISHO PHARMACEUTICAL CO. LTD (JP) 1987-05-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120014901-A1 Rinse-Off Conditioning Composition Comprising a Near-Terminal Branched Alcohol ITGB7, ARG1, ITGB1 LMNA 296/4885ALDH1A1 894/4885TSHR 3671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.